Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous xylocaine, magnesium sulfate, and amiodarone for prevention of arrhythmias after aortic declamping in CABG
IRCT2017040519470N55Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of lidocaine, magnesium sulfate and amiodarone in arrhythmia (3 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Prevention of cardiac arrhythmias after aortic declamping. Started Apr 2017; status: completed.
02
Drugs
lidocainemagnesium sulfateamiodarone
03
Conditions
arrhythmia
Beyond the preview
Go deeper on IRCT2017040519470N55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017040519470N55.